Fortis Healthcare Limited (FORTIS.BO)
- Previous Close
435.85 - Open
436.00 - Bid 428.95 x --
- Ask 429.15 x --
- Day's Range
426.40 - 436.00 - 52 Week Range
254.45 - 469.50 - Volume
42,387 - Avg. Volume
271,502 - Market Cap (intraday)
325.123B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
58.83 - EPS (TTM)
7.32 - Earnings Date May 21, 2024 - May 25, 2024
- Forward Dividend & Yield 1.00 (0.23%)
- Ex-Dividend Date Jul 20, 2023
- 1y Target Est
180.60
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Nepal, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. The company was founded in 1995 and is based in Gurugram, India.
www.fortishealthcare.com13,010
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: FORTIS.BO
Performance Overview: FORTIS.BO
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FORTIS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FORTIS.BO
Valuation Measures
Market Cap
329.05B
Enterprise Value
335.52B
Trailing P/E
59.46
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.93
Price/Book (mrq)
4.32
Enterprise Value/Revenue
5.03
Enterprise Value/EBITDA
27.74
Financial Highlights
Profitability and Income Statement
Profit Margin
8.19%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
67.5B
Net Income Avi to Common (ttm)
5.53B
Diluted EPS (ttm)
7.32
Balance Sheet and Cash Flow
Total Cash (mrq)
3.42B
Total Debt/Equity (mrq)
12.18%
Levered Free Cash Flow (ttm)
--